Product news

Share this article:
Gilead Sciences has received FDA approval for the marketing of Viread (tenofovir disoproxil fumarate), for the treatment of chronic hepatitis B in adults. Viread has been available in the US for the treatment of HIV infection in adults since 2001.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions